Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan

被引：0
|
作者：
Suzuki, Sho [1 ,2 ]
Ishibashi, Fumiaki [1 ,2 ]
Gotoda, Takuji [3 ]
机构：
[1] Int Univ Hlth, Dept Gastroenterol, Ichikawa, Japan
[2] Welf Ichikawa Hosp, Ichikawa, Japan
[3] Nihon Univ, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan
来源：
INTERNAL MEDICINE | 2023年 / 62卷 / 16期
关键词：
Helicobacter pylori; clarithromycin resistance; penicillin allergy; vonoprazan; THERAPY;
D O I：
10.2169/internalmedicine.1282-22
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2299 / 2300
页数：2
相关论文
共 50 条
  • [41] Single-Arm, Prospective, Interventional Study of Helicobacter pylori Eradication Rescue Therapy with Rifabutin, Metronidazole, and Vonoprazan
    Sue, Soichiro
    Ikeda, Ryosuke
    Ikeda, Aya
    Sato, Hiroki
    Kaneko, Hiroaki
    Irie, Kuniyasu
    Maeda, Shin
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [42] Low-dose or high-dose amoxicillin in vonoprazan-based dual therapy for Helicobacter pylori eradication? A systematic review and meta-analysis
    Ju, Kun-Ping
    Kong, Qing-Zhou
    Li, Yue-Yue
    Li, Yan-Qing
    HELICOBACTER, 2024, 29 (01)
  • [43] Vonoprazan-based high-dose dual therapy for H. pylori treatment failures: A pilot study
    Khoo, Stanley
    Chuah, Kee-Huat
    Leow, Alex Hwong-Ruey
    Goh, Khean-Lee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 272 - 272
  • [44] Seven-Day Vonoprazan-Based Triple Therapy as First-Line Helicobacter pylori Treatment in Comparison With Extended Sequential Therapy: A Randomized Controlled Trial
    Chiu, Yu-Tse
    Lee, Fu-Jen
    Kuo, Chen-Ya
    Chen, Yu-Tsung
    Lin, Yang-Chao
    Liang, Kai-Shun
    Wu, Chun-Ying
    Lin, Ro-Ting
    Lin, Jaw-Town
    Chang, Chi-Yang
    HELICOBACTER, 2024, 29 (04)
  • [45] Efficacy and safety of vonoprazan-based bismuth quadruple therapy for first-line Helicobacter pylori eradication: A large-scale, real-world study
    Zhou, Jihai
    Jia, Li
    Liu, Zhu
    Zhao, Wenen
    Liu, Lifeng
    Chen, Xin
    Gao, Fengyu
    MEDICINE, 2024, 103 (42) : e40170
  • [46] Vonoprazan-based therapy versus standard regimen for Helicobacter pylori infection management in Egypt: an open-label randomized controlled trial
    Yumna M. Shekeban
    Noha A. Hamdy
    Doaa A. Header
    Shwikar M. Ahmed
    Mai M. Helmy
    Scientific Reports, 15 (1)
  • [47] Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study
    Ying-Ying Han
    Lin Zhou
    Yun-Lian Hu
    Xiang-Wu Ding
    Hui Long
    Fei Liu
    Ming Xu
    Zhen-Yu Zhang
    Shuang-Ling Li
    Qiu-Yan Wang
    Cheng-Xia Su
    Yan Chen
    Jie Chen
    Ya Lin
    Pei-Yuan Li
    Journal of Gastroenterology, 2023, 58 : 1167 - 1177
  • [48] The Potential Benefits of Vonoprazan as Helicobacter pylori Infection Therapy
    Miftahussurur, Muhammad
    Putra, Boby Pratama
    Yamaoka, Yoshio
    PHARMACEUTICALS, 2020, 13 (10) : 1 - 14
  • [49] E-Test or Agar Dilution for Metronidazole Susceptibility Testing of Helicobacter pylori: Importance of the Prevalence of Metronidazole Resistance
    Chen, Jinnan
    Huang, Yu
    Ding, Zhaohui
    Liang, Xiao
    Lu, Hong
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [50] Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for Helicobacter pylori infection in China: a three-arm, randomised clinical trial protocol
    Han, ShaoWei
    Deng, ZiJie
    Cheung, KaShing
    Lyu, Tao
    Chan, PuiLing
    Li, Ying
    Ni, Li
    Luo, XiaPeng
    Li, Kuan
    BMC GASTROENTEROLOGY, 2023, 23 (01)
12345